![Card image cap](https://i0.wp.com/docmode.org/wp-content/uploads/2022/05/repiration-infection-scaled.jpg?fit=2560%2C1920&ssl=1)
ISM-1 new target protein for treating chronic lung diseases
A lung-resident protein, called isthmin 1 (ISM1), which is critical for restraining inflammation in a healthy lung by selectively eliminating the pro-inflammatory type of AMs, could be a potential target for developing a very promising biologic drug to treat COPD. A recent study, carried out by Dr Ge Ruowen, an associate professor at NUS Biological Sciences, and team, discovered this novel property of a protein found in human lungs which could lead to the development of biologic drugs that can potentially be used to treat COPD.